Heska Corp. (HSKA) Sets New 12-Month High at $44.99
Heska Corp. (NASDAQ:HSKA) hit a new 52-week high during mid-day trading on Monday . The stock traded as high as $44.99 and last traded at $43.40, with a volume of 65,124 shares traded. The stock had previously closed at $43.34.
Several equities research analysts have issued reports on the stock. TheStreet upgraded shares of Heska Corp. from a “hold” rating to a “buy” rating in a research report on Wednesday, May 25th. CL King assumed coverage on shares of Heska Corp. in a research report on Friday, April 1st. They set a “buy” rating for the company. Zacks Investment Research downgraded shares of Heska Corp. from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, July 5th. B. Riley restated a “buy” rating and set a $42.50 price objective on shares of Heska Corp. in a research report on Monday, May 9th. Finally, Sidoti initiated coverage on shares of Heska Corp. in a research report on Friday, July 1st. They set a “buy” rating and a $49.00 price objective for the company. Five equities research analysts have rated the stock with a buy rating, Heska Corp. has an average rating of “Buy” and an average target price of $46.50.
The firm has a market capitalization of $289.80 million and a P/E ratio of 53.15. The firm’s 50 day moving average price is $37.43 and its 200-day moving average price is $34.15.
Heska Corp. (NASDAQ:HSKA) last posted its earnings results on Tuesday, May 3rd. The company reported $0.17 earnings per share for the quarter, topping the Zacks’ consensus estimate of ($0.02) by $0.19. The business earned $27.10 million during the quarter, compared to analyst estimates of $23.32 million. Analysts predict that Heska Corp. will post $0.85 EPS for the current year.
In other Heska Corp. news, CEO Kevin S. Wilson sold 10,000 shares of the company’s stock in a transaction dated Friday, July 8th. The shares were sold at an average price of $42.37, for a total value of $423,700.00. Following the completion of the sale, the chief executive officer now directly owns 150,000 shares of the company’s stock, valued at approximately $6,355,500. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Jason A. Napolitano sold 5,000 shares of the company’s stock in a transaction dated Tuesday, May 3rd. The stock was sold at an average price of $35.75, for a total transaction of $178,750.00. Following the completion of the sale, the chief financial officer now directly owns 63,544 shares of the company’s stock, valued at $2,271,698. The disclosure for this sale can be found here.
Heska Corporation develops, manufactures, markets, sells and supports veterinary products. The Company focuses on the canine and feline companion animal health markets. Its segments include Core Companion Animal Health segment, which includes, primarily for canine and feline use, blood testing instruments and supplies, digital imaging products, software and services, and single use products and services, such as heartworm diagnostic tests, heartworm preventive products, allergy immunotherapy products and allergy testing, and Other Vaccines, Pharmaceuticals and Products segment, which includes private label vaccine and pharmaceutical production, primarily for cattle but also for other animals, including small mammals.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.